Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
- PMID: 30002200
- DOI: 10.2337/dc18-0999
Differences Between Randomized Clinical Trial Patients and Real-World Initiators of the Glucagon-Like Peptide 1 Receptor Agonist Liraglutide
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources
